Amylyx Pharmaceuticals achieved what all upstart drugmakers hope to accomplish. In less than 10...
The Federal Trade Commission on Tuesday released a long-awaited report criticizing the pharmacy benefit...
Dive Brief: Biotechnology company HilleVax on Monday said it will halt development of an...
Eli Lilly plans to spend $3.2 billion acquiring a Massachusetts-based biotechnology company and its...
Dive Brief: Two years after canceling an initial public offering, Artiva Biotherapeutics has filed...
Dive Brief: UniQure will sell a gene therapy production plant in Lexington, Massachusetts, to...
Dive Brief: Cartesian Therapeutics on Tuesday said an experimental cell therapy it’s developing succeeded...
Two of last year’s largest biotechnology company acquisitions centered on a new type of...
Today, a brief rundown of news from Beacon Therapeutics and Regeneron Pharmaceuticals, as well...
Dive Brief: CureVac, a specialist in messenger RNA-based therapies, disclosed Wednesday plans to lay...
The U.S. government has awarded $176 million to vaccine maker Moderna for development of...
The Food and Drug Administration on Tuesday approved a new Alzheimer’s disease drug from...
Dive Brief: Eisai and Bristol Myers Squibb will cancel a collaboration on a dual-acting...
Dive Brief: Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics...
Viral contamination is a threat to biopharmaceutical product development.1 Contaminants can be present in...
Immune drug developer Alumis has raised $210 million in one of the biotechnology sector’s...
Dive Brief: The U.S. Supreme Court overturned the Chevron doctrine on Friday in a...
Today, a brief rundown of news from PTC Therapeutics, Esperion Therapeutics and Coherus Biosciences,...
Dive Brief: The Food and Drug Administration has rejected a gene therapy developed by...
Dive Brief: Advisers to the Centers for Disease Control and Prevention on Thursday unanimously...
Dive Brief: 2seventy Bio is shrinking further, announcing Thursday the sale of a hemophilia...
Dive Brief: Shares of Moderna, Pfizer and GSK fell as advisers to the Centers...
Ozempic and GLP-1 drugs like it became household names due to their potent weight...
Dive Brief: Novo Nordisk will end a Phase 3 clinical trial of a hypertension...
Dive Brief: Wave Life Sciences on Tuesday said it will meet with regulators to...
Dive Brief: Novo Nordisk will spend $4.1 billion to build a new U.S. factory...
Exsilio Therapeutics, a biotechnology startup led by a former Moderna executive, emerged from stealth...
Today, a brief rundown of news from Altimmune, Jiangsu Hengrui, Eli Lilly and others that...
Diseases aren’t just disorders in physiological systems, and it’s not possible to cure them...
Dive Brief: Amazon has expanded its generic drug savings program to Prime members on...
Dive Brief: Twice-yearly shots of a Gilead Sciences HIV drug were so effective at...
Dive Brief: PTC Therapeutics said Thursday it can resume a Phase 2 trial of...
Today, a brief rundown of news from Jazz Pharma, Vanda Pharmaceuticals, ITM, Ashibio and...
Peter Marks is again at the center of a controversial Food and Drug Administration...
An experimental weight loss shot developed by Denmark-based Zealand Pharma helped people with obesity...
The Food and Drug Administration has substantially loosened limits on the first gene therapy...
Roche has partnered with Ascidian Therapeutics to develop so-called “RNA exon editing” drugs, the...
Today, a brief rundown of news from Belharra Therapeutics, AstraZeneca, Regenxbio and Tasyha Gene...
Dive Brief: Intra-Cellular Therapies plans to seek clearance to sell its medicine Caplyta for...
Dive Brief: The Food and Drug Administration on Monday approved a new vaccine from...
Dive Brief: An experimental pill developed by Takeda to treat the rare epilepsies Dravet...
AbbVie is securing its place in an emerging gastrointestinal disease drug field, paying China-based...
Dive Brief: Moderna said its next-generation COVID-19 vaccine succeeded in a Phase 3 study,...
The Supreme Court on Thursday unanimously ruled an anti-abortion group contesting the Food and...
Dive Brief: Flagship Pioneering will partner with biotechnology startup ProFound Therapeutics to search for...
Pfizer’s experimental gene therapy for Duchenne muscular dystrophy didn’t improve the motor function of...
Dive Brief: The Food and Drug Administration on Monday cleared a new treatment option...
Approval of Eli Lilly’s experimental Alzheimer’s disease drug donanemab would help drive sales of...
Dive Brief: Moderna on Monday said a combination flu and COVID-19 shot it’s developing...
An experimental and closely watched medicine for Alzheimer’s disease is one step closer to...
As healthcare moves toward the shared goal of improving patient care more economically, stakeholders...
Dive Brief: Seres Therapeutics plans to sell all the rights to its microbiome pill...
A group of advisers to the Food and Drug Administration on Wednesday unanimously recommended...
After a turbulent few years, 2024 has given the biotechnology industry some signs of...
Today, several brief updates from BioPharma Dive Reporter Gwendolyn Wu, who spent this week...
Long dismissed by top scientists and drug regulators, the use of psychedelics to treat...
Dive Brief: Expert advisers to the Food and Drug Administration will need to weigh...
Listen to the article 2 min This audio is auto-generated. Please let us know...
Dive Brief: Anat Ashkenazi will leave Eli Lilly’s executive suite at the end of...
Today, a brief rundown of news from Eli Lilly, Cytokinetics and AbbVie, as well...
Dive Brief: Illumina’s board of directors has approved a spinoff of Grail, targeting June...
Medical experts who advise the Food and Drug Administration are not convinced MDMA is...
Dive Brief: An experimental GLP-1 pill helped people with obesity lose significantly more weight...
BioPharma Dive is testing out a new format rounding up smaller updates from around...
Liquid biopsy has emerged as a revolutionary tool for clinical trials, offering cellular and...
Two years ago, a drug called Enhertu changed the way doctors thought about treating...
An accelerated approval for Gilead Sciences’ cancer drug Trodelvy could be in question after...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial...
Food and Drug Administration scientists have reservations about a potential new treatment for post-traumatic...
Otsuka America, a subsidiary of the Japanese drug and device maker, this month launched...
Dive Brief: Immunovant told investors Wednesday that it’s shifting resources to focus on a...
Dive Brief: Gameto, a biotechnology company developing new treatments for fertility, has raised $33...
Dive Brief: Agios Pharmaceuticals has agreed to sell to Royalty Pharma rights to royalties...
New Jersey-based drugmaker Insmed gained more than $3 billion in market value Tuesday after...
Artificial intelligence (AI) has sparked a revolution in the pharmaceutical industry, reshaping the way...
Dive Brief: Shares in Cytokinetics sank by about one-fifth Thursday on news of a...
Dive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million...
Eli Lilly plans to spend another $5.3 billion building production capacity for its popular...
A top Food and Drug Administration official on Friday again advocated for the speedy...
An older form of hormone therapy taken to ease the symptoms of menopause could...
Orna Therapeutics, a young biotechnology company focused on a flashy area of genetic research,...
Dive Brief: Biogen is scooping up a closely held immunology startup to bring more...
Pfizer, already in the midst of an aggressive effort to trim spending, on Wednesday...
Dive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily...
Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer,...
British biotechnology startup Pheon Therapeutics has raised another $120 million in venture funding, riding...
Forbion, a well-known backer of life sciences startups, is leading an investment round for...
Dr. Zocca brings more than 20 years of experience in the biotechnology field and...
Biogen and Ionis Pharmaceuticals are stopping development of an experimental drug for ALS following...
Dive Brief: An experimental Roche drug helped people with obesity lose an average of...
A once-weekly form of insulin being developed by Eli Lilly proved just as effective...
Dive Brief: The Food and Drug Administration on Thursday granted accelerated approval to a...
New data from two late-stage studies of an experimental Bayer drug show it reduced...
Four life science investors are pouring $400 million into a new biotechnology startup that’s...
San Francisco-based Bolt Biotherapeutics on Tuesday said it is ending development of its lead...
One of the developers behind the Alzheimer’s disease drug Leqembi has set new revenue...
FogPharma and Artbio, two buzzy biotechnology companies, are betting they can combine their respective...
German pharmaceutical company Bayer eliminated 1,500 roles during the first three months of the...
Listen to the article 3 min This audio is auto-generated. Please let us know...
Takeda Pharmaceutical is betting potentially billions of dollars on drugs designed to slow Alzheimer’s...
Dive Brief: A profoundly deaf baby who received Regeneron’s experimental gene therapy was able...
Novo Nordisk is again turning to a Flagship Pioneering startup to find new weight...
Dive Brief: Sanofi will pay vaccine maker Novavax $500 million and take a small...
Dive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi,...
Moderna on Friday said the Food and Drug Administration has postponed an approval decision...
Dive Brief: Royalty Pharma will pay biotechnology startup ImmuNext $525 million for the right...
Dive Brief: Takeda plans to simplify how its workforce is organized, cut spending and...
Dive Brief: AstraZeneca will no longer manufacture or supply its COVID-19 vaccine Vaxzevria, announcing Tuesday...
Patents reward drugmakers for their inventions and, effectively, the large sums of money they...
A young boy enrolled in a clinical trial testing an experimental Pfizer gene therapy...
Dive Brief: Verve Therapeutics has treated the first participant in a recently begun clinical...
Physicians at Children’s National Hospital in Washington, D.C., last week collected the stem cells...
Gossamer Bio has sold rights to an experimental drug that could rival a new...
Dive Brief: A group of well-known biotechnology investors is putting $200 million into a...
Cancer research is always evolving, as scientists search for ways to combat the tricks...
Dive Brief: The gene editing company Metagenomi, which went public earlier this year, said...
Dive Brief: An experimental drug from CG Oncology has driven bladder cancers into remission...
Mariana Oncology arrived at the J.P. Morgan Healthcare Conference this past January with momentum....
Dive Brief: Amgen shares soared by double digits Friday following its announcement an obesity...
Dive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it has...
Dive Brief: Sales of Novo Nordisk’s obesity drug Wegovy slowed over the first three...
Pfizer’s rare disease drug Vyndaqel may be its least well known blockbuster medicine. The...
Dive Brief: GSK on Wednesday raised its financial forecasts for the year following strong...
Federal officials said a new rule expanding regulatory oversight of laboratory-developed tests will protect...
Eli Lilly expects that, by the second half of this year, it will be...
Dive Brief: Prime Medicine will soon begin the first clinical trial of a new...
Dive Brief: The Food and Drug Administration on Monday released a final rule strengthening...
Biogen plans to increase the number of salespeople selling the company’s prized drug for...
Dive Brief: Biogen has seen “encouraging early trends” in the launch of its postpartum...
Dive Brief: Regeneron Pharmaceuticals is upping its investment in genetic medicine, announcing Thursday a...
Bristol Myers Squibb will cut 6% of its workforce in a restructuring meant to...
Dive Brief: The Food and Drug Administration on Friday approved a new gene therapy...
Dive Brief: U.S. Humira sales fell 40% year over year during the first three...
Dive Brief: BioMarin on Wednesday said it’s wrapped up a pipeline review and will...
AstraZeneca’s revenue and profits grew at a rapid clip over the first three months...
Investors who had hoped Biogen would do another flashy deal this year may not...
Moderna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday...
Sales of Novartis drugs for heart failure, psoriasis and multiple sclerosis were stronger over...
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the...
Dive Brief: Eli Lilly on Monday said it will acquire a drug plant from...
Dive Brief: French pharmaceutical company Ipsen will work with privately held biotechnology company Skyhawk...
Dive Brief: Uwe Schoenbeck, a biotech veteran who most recently was chief scientific officer...
Dive Brief: Alvotech and Teva on Tuesday won Food and Drug Administration approval for...
Dive Brief: Metsera, a richly funded biotechnology startup, launched Thursday with a portfolio of...
Cerevel Therapeutics, a biotechnology company in the midst of being acquired by AbbVie, on...
The Food and Drug Administration has made a medicine from Roche the first specifically...
Dive Brief: Alvotech and U.S. commercial partner Teva have signed a “long-term agreement” with...
Vertex Pharmaceuticals is vying for approval of an experimental and closely watched painkiller that...
Dive Brief: 23andMe CEO Anne Wojcicki plans to take the DNA testing company private,...
An experimental drug designed to improve brain function in people with nerve-degrading disorders has...
Fresh clinical trial results for Eli Lilly’s drug Zepbound point to a new use...
An antipsychotic drug from Intra-Cellular Therapies appears to also work as an add-on therapy...
Dive Brief: Sales of Johnson & Johnson’s multiple myeloma medicine Tecvayli more than doubled...
Shares of Neumora Therapeutics fell Monday after the company disclosed a small clinical trial...
Dive Brief: Roche’s new dual-acting blood cancer drug Columvi combined with chemotherapy helped people...
When Katherine Wisner began studying postpartum mental health in the 1980s, the field barely...
Dive Brief: Biotechnology company Rallybio is partnering with Johnson & Johnson, announcing a collaboration...
Dive Brief: Genentech, the research subsidiary of Swiss pharmaceutical giant Roche, has decided to...
Initial public offerings by biotechnology companies reached pre-pandemic levels during the first quarter, with...
Dive Brief: Novo Nordisk and Eli Lilly drugs to treat diabetes and obesity have...
The U.S. Department of Justice on Wednesday accused Regeneron of defrauding Medicare by knowingly...
Dive Brief: Biotechnology company Century Therapeutics is expanding its autoimmune disease research with a...
Dive Brief: Vertex Pharmaceuticals on Wednesday said it would buy biotechnology company Alpine Immune...
Dive Brief: Novartis will pause enrollment in certain clinical trials of its breast cancer...
Dive Brief: Pfizer on Tuesday said it plans to ask regulators to broaden the...
Hoping to repeat a recent success story, the biotechnology startup creator PureTech Health has...
Private funding for biotechnology startups rose during the first three months of the year,...
Dive Brief: Novo Nordisk’s weight loss drug Wegovy helped people with obesity, diabetes and...
Dive Brief: Diagonal Therapeutics, a biotechnology startup focused on creating antibodies that activate, rather...
Amylyx Pharmaceuticals is pulling from market one of the few approved treatments for ALS....
Dive Brief: Swiss drugmaker Basilea Pharmaceutica on Wednesday won Food and Drug Administration approval...
Johnson & Johnson has agreed to acquire Shockwave Medical for approximately $13.1 billion, the...
Dive Brief: The Food and Drug Administration has cleared Bristol Myers Squibb and 2seventy...
Dive Brief: Boehringer Ingelheim is laying off staff in response to sluggish adoption of...
Contineum Therapeutics has raised $110 million in an initial public offering, the biotechnology industry’s...
Dive Brief: Merck & Co. has begun a large clinical trial testing an experimental...
Dive Brief: Genmab said Wednesday it’s agreed to pay $1.8 billion for ProfoundBio, gaining...
Dive Brief: A third biotechnology company from the startup creator Paragon Therapeutics is heading...
Dive Brief: Acorda Therapeutics has filed for bankruptcy and, on Monday, announced it has...
Dive Brief: An experimental drug being developed by a subsidiary of Roivant Sciences succeeded...
The year started well for the biotechnology industry. Steady dealmaking coupled with a rebound...
Dive Brief: Vertex Pharmaceuticals on Monday said it will advance an experimental kidney disease...
The Food and Drug Administration on Tuesday approved a new Merck & Co. drug...
A large clinical trial has found that a drug commonly used by patients with...
Two years after Art Krieg sold his last biotechnology company to Regeneron Pharmaceuticals, the...
When the Food and Drug Administration expanded approval of Novo Nordisk’s weight loss medicine...
Dive Brief: Bristol Myers Squibb’s cancer pill Krazati helped people with a certain kind...
Dive Brief: Gilead Sciences will pay $30 million and invest another $13.5 million in...
Dive Brief: The Food and Drug Administration has approved Akebia Therapeutics’ blood-boosting pill Vafseo for...
Dive Brief: Boundless Bio, a cancer drug developer backed by Bayer and Arch Venture...
Dive Brief: Blackstone Life Sciences will invest as much as $750 million on influenza...
The Supreme Court on Tuesday heard legal arguments in a high-profile case involving the...
Dive Brief: A dual-acting weight loss pill from Viking Therapeutics helped people with obesity...
An experimental drug from Axsome Therapeutics was successful in a late-stage clinical trial evaluating...
Dive Brief: Abbvie is expanding its pipeline of inflammatory disease drugs, announcing Monday a...
